000 01549 a2200469 4500
005 20250513200147.0
264 0 _c19991228
008 199912s 0 0 eng d
022 _a0002-9440
024 7 _a10.1016/S0002-9440(10)65507-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNielsen, G P
245 0 0 _aMalignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.
_h[electronic resource]
260 _bThe American journal of pathology
_cDec 1999
300 _a1879-84 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCell Transformation, Neoplastic
_xgenetics
650 0 4 _aChild
650 0 4 _aCyclin-Dependent Kinase Inhibitor p16
_xmetabolism
650 0 4 _aDNA Methylation
650 0 4 _aFemale
650 0 4 _aGene Deletion
650 0 4 _aGenes, p16
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeurofibroma
_xgenetics
650 0 4 _aNeurofibromatosis 1
_xgenetics
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPolymorphism, Single-Stranded Conformational
700 1 _aStemmer-Rachamimov, A O
700 1 _aIno, Y
700 1 _aMoller, M B
700 1 _aRosenberg, A E
700 1 _aLouis, D N
773 0 _tThe American journal of pathology
_gvol. 155
_gno. 6
_gp. 1879-84
856 4 0 _uhttps://doi.org/10.1016/S0002-9440(10)65507-1
_zAvailable from publisher's website
999 _c10551993
_d10551993